FAM148C Inhibitors

Rapamycin, an mTOR inhibitor, suppresses mTORC1 signaling. FAM148C is a protein that may interact with components of the mTOR pathway. Inhibition of mTORC1 can reduce the phosphorylation of downstream targets necessary for protein synthesis, which in turn could decrease the functional activity of FAM148C by limiting its post-translational modification or abundance.

LY294002 is a PI3K inhibitor that blocks the PI3K/AKT/mTOR signaling pathway. Since FAM148C may interact with components of this pathway, the inhibition of PI3K can lead to reduced AKT phosphorylation and subsequent decreased activation of mTORC1. This results in diminished activity of proteins regulated by mTORC1, potentially including FAM148C.

Wortmannin is another PI3K inhibitor that could indirectly decrease the functional activity of FAM148C by inhibiting AKT phosphorylation, leading to reduced mTOR signaling. This cascade effect from PI3K to mTOR could decrease the activities of proteins that are downstream of mTOR, such as FAM148C.

PD98059 is an MEK inhibitor which could indirectly inhibit the activity of FAM148C by preventing the activation of the ERK/MAPK signaling pathway. ERK/MAPK is involved in various cellular processes including growth and differentiation, and its inhibition could affect proteins associated with this pathway.

U0126 is a selective inhibitor of both MEK1 and MEK2, which are upstream of ERK in the MAPK pathway. Inhibition of MEK1/2 by U0126 could potentially decrease the phosphorylation and activity of ERK, which in turn could diminish the functional activities of ERK-dependent proteins, including possibly FAM148C.

SB203580 is a p38 MAPK inhibitor that might inhibit the activity of FAM148C indirectly by inhibiting p38 MAPK, which is involved in stress responses. Inhibition of p38 MAPK can reduce the activity of downstream proteins that play roles in cellular stress responses, potentially affecting FAM148C activity.

SP600125 is an inhibitor of JNK, which indirectly could affect FAM148C. JNK pathway is implicated in apoptosis and cell differentiation, and its inhibition could decrease the functional activities of proteins modulated by JNK signaling.

PP242 is an ATP-competitive selective inhibitor of mTOR kinase activity. By inhibiting mTOR, PP242 can reduce the activity of proteins regulated by mTOR signaling, potentially including FAM148C, by preventing their phosphorylation and activation.

NVP-BEZ235 is a dual PI3K/mTOR inhibitor. By inhibiting both PI3K and mTOR, it could indirectly inhibit the functional activity of FAM148C by decreasing the activity of the PI3K/AKT/mTOR pathway, reducing the phosphorylation of proteins involved in this pathway.

Torin 1 is a potent and selective mTOR inhibitor that could reduce the functional activity of FAM148C by inhibiting mTORC1 and mTORC2 complexes, leading to a decrease in the phosphorylation of downstream targets regulated by these complexes.